Beam Therapeutics's market cap is currently $2.44B. The company's EPS TTM is $-1; its P/E ratio is ―; Beam Therapeutics is scheduled to report earnings on August 5, 2025, and the estimated EPS forecast is $-1.05. See an overview of income statement, balance sheet, and cash flow financials.
